__timestamp | BeiGene, Ltd. | Walgreens Boots Alliance, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 21862000 | 54823000000 |
Thursday, January 1, 2015 | 58250000 | 76691000000 |
Friday, January 1, 2016 | 98033000 | 87477000000 |
Sunday, January 1, 2017 | 273992000 | 89052000000 |
Monday, January 1, 2018 | 707710000 | 100745000000 |
Tuesday, January 1, 2019 | 998528000 | 91915000000 |
Wednesday, January 1, 2020 | 1365534000 | 95905000000 |
Friday, January 1, 2021 | 1624145000 | 104442000000 |
Saturday, January 1, 2022 | 1926983000 | 104437000000 |
Sunday, January 1, 2023 | 379920000 | 112009000000 |
Monday, January 1, 2024 | 121134000000 |
Data in motion
In the ever-evolving landscape of global commerce, understanding cost efficiency is paramount. This analysis delves into the cost of revenue trends for BeiGene, Ltd. and Walgreens Boots Alliance, Inc. from 2014 to 2023. Over this period, Walgreens Boots Alliance consistently demonstrated a robust cost structure, with its cost of revenue peaking at approximately $112 billion in 2023, marking a 104% increase from 2014. In contrast, BeiGene, Ltd. experienced a dramatic rise, with its cost of revenue surging by over 8,700% from 2014 to 2022, before a notable dip in 2023. This stark contrast highlights the differing scales and operational strategies of these two industry giants. While Walgreens Boots Alliance maintains steady growth, BeiGene's fluctuations suggest a dynamic, albeit volatile, expansion strategy. Missing data for 2024 suggests a need for cautious interpretation of future trends.
Cost of Revenue: Key Insights for Eli Lilly and Company and BeiGene, Ltd.
Cost of Revenue: Key Insights for BeiGene, Ltd. and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: BeiGene, Ltd. and Alkermes plc
Cost Insights: Breaking Down BeiGene, Ltd. and Iovance Biotherapeutics, Inc.'s Expenses
BeiGene, Ltd. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BeiGene, Ltd. vs Viridian Therapeutics, Inc.
Cost Insights: Breaking Down Viatris Inc. and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Mesoblast Limited